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The Elongator complex catalyzes posttranscriptional tRNA modifications by attaching
carboxy-methyl (cm5) moieties to uridine bases located in the wobble position. The catalytic
subunit Elp3 is highly conserved and harbors two individual subdomains, a radical S-adenosyl
methionine (rSAM) and a lysine acetyltransferase (KAT) domain. The details of its mod-
ification reaction cycle and particularly the substrate specificity of its KAT domain remain
elusive. Here, we present the co-crystal structure of bacterial Elp3 (DmcElp3) bound to an
acetyl-CoA analog and compare it to the structure of a monomeric archaeal Elp3 from
Methanocaldococcus infernus (MinElp3). Furthermore, we identify crucial active site residues,
confirm the importance of the extended N-terminus for substrate recognition and uncover
the specific induction of acetyl-CoA hydrolysis by different tRNA species. In summary, our
results establish the clinically relevant Elongator subunit as a non-canonical acetyltransferase
and genuine tRNA modification enzyme.
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Over 170 different RNA base modifications are currentlydescribed1 and a majority is found in tRNAmolecules of allthree domains of life2,3. The functions of tRNA modifica-
tions can be separated into three main categories depending on the
modified positions, either (i) stabilizing the structural integrity of
the core tRNA fold4, (ii) contributing to the correct amino-acylation
of respective tRNAs at the acceptor stem loop5 or (iii) enhancing
the decoding potential and translation fidelity at the ribosome6,7.
The latter group of tRNA modifications is mostly found around the
anticodon stem loop (ASL), particularly at the so-called “hot spot”
positions 34 and 372,7,8. As modifications in this region can provide
additional chemical bonds between the ASL and its cognate and
near-cognate codons during the ribosomal decoding process,
they are crucial for fine-tuning translation elongation8–11 and co-
translational folding dynamics12,13. In agreement, the lack of certain
uridine modifications in the wobble position (U34), such as
5-methoxycarbonylmethyl (mcm5), 5-carbamoylmethyl (ncm5)
and 5-methoxy-carbonyl-methyl-2-thio (mcm5s2), were shown to
induce cellular stress14, increase intracellular protein aggregation
and disturb proteome homeostasis15,16.
The eukaryotic Elongator complex was initially described as a
transcription-related elongation factor due to its association with
hyper-phosphorylated RNA Polymerase II17 and the predicted
presence of a potential histone/lysine acetyltransferase (KAT)
domain in its catalytic Elp3 subunit18. Although some recent
reports still follow that initial hypothesis, an increasing number of
studies supports the idea that Elongator in fact represents a
genuine tRNA modification enzyme, which catalyzes the cm5U34
modification, representing the first step in a cascade leading to
different types of U34 modifications19–22. The cm5 moiety can be
subsequently methylated by the methyl transferase Trm9 result-
ing in mcm5U34 ref. 23. In three yeast tRNAs, namely tRNA-
Glu
UUC, tRNAGlnUUG, and tRNALysUUU, this “primal” Elongator
modification is succeeded by an additional thiolation24 leading to
mcm5s2U34 or is converted into ncm5U34 by a yet unknown
mechanism in other tRNA species25.
The fully assembled eukaryotic complex consists of two copies
of each of its six subunits (Elp1-6), which are arranged in two-
independent modules, the catalytic Elp123 and the associated
Elp456 sub-complexes26–28. All six Elongator subunits are highly
conserved among eukaryotes and the Elp3 subunit is even found
in all three domains of life, including all archaea and some bac-
terial clades20. Elp3 acts as the catalytic subunit, but the loss of
any of the six subunits results in hypo-modified U34 tRNAs in
yeast19,29, indicating that the complete integrity of the complex is
important for its function. The key role of Elongator in main-
taining the stringent homeostasis of the cellular proteome
explains the pleotropic phenotypes associated with Elp3 defi-
ciency, including neurogenesis30, DNA repair31, exocytosis32,
genome demethylation33, protein acetylation34,35, mitochondria
dysfunction36, and tRNA modification22. Moreover, patient-
derived mutations and deficiencies in different Elongator sub-
units are associated with severe human diseases37,38, such as
cancer39 and neurodegenerative diseases40, including familial
dysautonomia41, amyotrophic lateral sclerosis42, intellectual dis-
abilities43, and ataxia44.
Over the last decade, significant progress has been made
towards an understanding of the structural and functional
rationale behind the modification reaction conducted by the
catalytically active Elp3 subunit20,21,45,46. We previously deter-
mined the high resolution crystal structure of the bacterial Elp3
homologue from Dehalococcoides mccartyi (DmcElp3), revealing
the tight interplay between the involved radical S-adenosyl
methionine (rSAM) and KAT domains. The rSAM domain of
Elp3 is highly similar to RlmN47, which also contains a Fe–S
cluster and methylates rRNAs and tRNAs using its reductive
SAM cleavage activity48. The C-terminal KAT domain is highly
similar to the known superfamily of GCN5-like acetyl trans-
ferases49, which bind linear peptides and acetylate target lysines
via their acetyl-CoA hydrolysis activity50. The two domains form
a large domain interface, which blocks the canonical KAT
peptide-binding site, and a partially disordered central linker
region coordinates a Zn-ion in between rSAM and KAT. The two
domains form a cleft that contains several highly conserved basic
residues, which bind and accommodate the tRNA anticodon stem
loop (ASL). The current model of a radical based Elp3-mediated
cm5-modification reaction is proposed as follows (i) Elp3 recruits
SAM and cleaves it to generate a 5’deoxyadenosine radical (5’-
dA) in the rSAM domain, (ii) Elp3 hydrolyzes acetyl-CoA in the
KAT domain and (iii) an acetyl radical is formed by the products
of the two domains and (iv) is transferred onto the C5 position of
U34 in the bound tRNA molecule.
In comparison to the overwhelming amount of recently pub-
lished phenotypical and clinical studies on the Elongator com-
plex, the number of available structural and biochemical data
remain minuscule. However, without a deeper mechanistic
knowledge of the underlying mechanisms in different organisms,
the genuine cellular function of Elongator and the details of the
reaction cycle and its intermediates remain elusive and highly
speculative. Here, we present the structure of DmcElp3 bound to
an acetyl-CoA derivative that reveals ligand coordination and
allows the precise identification of several active site residues. In
addition, we present the crystal structure of monomeric Elp3
from archaea and compare it to the previously known dimeric
bacterial Elp3 structure. Furthermore, we are able to measure
acetyl-CoA hydrolysis rates and tRNA binding activities for dif-
ferent Elp3 homologues. Last but not least, we provide bio-
chemical evidence that specific tRNAs, but neither histone or
tubulin peptides nor other nucleic acids, act as the exclusive
trigger for acetyl-CoA hydrolysis in bacterial, archaeal and
eukaryotic Elp3s. Our results define Elongator and its
Elp3 subunit as a genuine tRNA editing enzyme in all three
domains of life and resolve the ongoing debate about a direct
involvement of Elongator in any cellular activity other than tRNA
modification.
Results
DmcElp3 binds acetyl-CoA like other KAT domain proteins.
We have previously determined the crystal structure of Elp3 from
Dehalococcoides mccartyi and identified the potential acetyl-CoA
binding pocket and a specific blocking loop that seems to func-
tionally link acetyl-CoA- and tRNA-binding21. Furthermore, we
found that several potent key residues residing in the acetyl-CoA
binding pocket (e.g. K77, K193, E386, and Y441) are conserved
among various Elp3s and showed that the equivalent
single amino acid substitutions in yeast lead to Elongator
loss-of-function phenotypes. To obtain detailed structural
insights into acetyl-CoA coordination, we combined the respec-
tive blocking loop deletion (DmcElp3390–406(GSGSG)) with
additional active site mutations (e.g. E386A, H388A, R411T) for
co-crystallization trials in the presence of acetyl-CoA and dif-
ferent acetyl-CoA analogues. We successfully co-crystallized
DmcElp3390–406(GSGSG)/E386A (Supplementary Fig. 1a) in com-
plex with desulfo-CoA (DmcElp3-DCA) using similar crystal-
lization conditions as for apo DmcElp3. We solved and refined
the structure at 2.7 Å resolution using DmcElp3 (PDB ID 5L7L)
as search model for molecular replacement (Fig. 1a and Table 1).
The overall structure of DmcElp3-DCA closely matches the
structure of DmcElp3 (Supplementary Fig. 1b), indicating that
ligand binding has very little or no influence on the structural
arrangement of the two domains or the Fe–S cluster mediated
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rSAM dimerization. This observation is consistent with our
previous results from SAXS analyses performed in the presence
and absence of acetyl-CoA21. The density of DCA is clearly visible
in initial, refined and simulated annealing composite omit maps
and allowed its unambiguous placement (Fig. 1b). DCA is
structurally similar to acetyl-CoA but lacks both, the acetyl group
as well as the thiol-moiety, and therefore represents a post-
cleavage product analogue. DCA binds to the KAT domain of
DmcElp3 in a similar way as acetyl-CoA is coordinated by the
active site of GCN5 from Tetrahymena (Supplementary Fig. 1b).
In detail, the two phosphate groups of DCA are in close proximity
to the glycine residues residing at the start of the blocking loop.
The rest of DCA, including pantothenic acid and β-mercap-
toethylamine, are pointing deeper into the predicted binding
pocket. Furthermore, previously identified conserved residues,
including K77, K193, and Y441, are involved in ligand binding
and in close proximity to DCA (Fig. 1c and Supplementary
Fig. 1c). The β-mercaptoethylamine part of DCA was not clearly
resolved in our densities, presumably because this part of the
ligand is flexible in the absence of the missing tRNA substrate.
Considering the observation that DCA stays bound even in the
absence of the transferable acetyl group, we conclude that the
cleavage products stay associated with the KAT domain until the
next round of modification is initiated.
Structural comparison between bacterial and archaeal Elp3.
DmcElp3 represents a rare example of bacterial Elp3s, but shares
high sequence similarity with archaeal Elp3s, which also lack
genes for all the other five eukaryotic Elongator subunits.
Although DmcElp3 and Methanocaldococcus infernus Elp3
(MinElp3) share 50% sequence identity, MinElp3 harbors an
extended N-terminus (aa 1–75). This flexible region enriched in
basic residues is present in most archaeal and eukaryotic
Elp3 sequences, but completely absent from DmcElp321. To gain
further structural and functional insights into archaeal and more
closely related eukaryotic Elp3s, we expressed and purified
recombinant full length MinElp3 under aerobic conditions.
Unlike DmcElp3, which shows two discrete oligomeric states21,
full length MinElp3 exclusively forms monomers. We further
generated five different N-terminally truncated versions
(MinElp3Δ1–19, MinElp3Δ1–41, MinElp3Δ1–46, MinElp3Δ1–54,
MinElp3Δ1–68) to facilitate crystallization. In comparison to the
full length protein, all five truncations exhibited two discrete
concentration-independent oligomeric states in size exclusion
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Fig. 1 The crystal structure of DCA bound to DmcElp3390–406(GSGSG)/E386A. a Overall structure of DmcElp3-DCA in cartoon representation. The rSAM
domain (blue), KAT domain (pink), and acetyl-CoA blocking loop (olive) are highlighted. Disordered loops are shown using dotted lines. Fe–S cluster
binding and zinc binding residues are highlighted in green. Fe–S cluster (orange and yellow spheres) and PO4 (orange and red spheres) are highlighted.
Respective amino acid numbers are indicated. b The Fo–Fc simulated annealing omit map (green) of DCA and the refined 2Fo–Fc map (gray) are shown at
1.5 σ in the binding pocket of DmcElp3390–406(GSGSG)/E386A. The model of DmcElp3 is shown in cartoon and the located DCA molecule in ball and sticks
representations. c The interaction of DCA and the residues residing in the binding pocket of DmcElp3390–406(GSGSG)/E386A. Hydrogen bonds are highlighted
in dotted lines while bond lengths were analyzed using LigPlot. All involved residues and distance are indicated
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chromatography, namely monomers and dimers (Supplementary
Fig. 2a). All purified MinElp3 samples appeared slightly pink,
suggesting the presence of an Fe–S cluster in a minority of
monomeric and dimeric MinElp3 molecules even under aerobic
purification conditions. Moreover, the Fe–S cluster loop (like in
DmcElp3) directly contributes to the dimer formation of trun-
cated MinElp3 (Supplementary Fig. 2a). Notably, the monomeric
forms of truncated MinElp3 elute earlier from the gel filtration
column and therefore appear to be larger than expected. We
confirmed their theoretical masses by SDS-PAGE and light
scattering (RALS and LALS) measurements and speculate that the
N-terminus could also be involved in the compaction of the
bacterial and archaeal Elp3 proteins.
We used full length and truncated versions of purified MinElp3
in crystallization trials and obtained well-diffracting crystals for
monomeric MinElp3Δ1–19, MinElp3Δ1–46, and MinElp3Δ1–54. We
solved their structures using a poly-alanine model of DmcElp3 via
molecular replacement at 1.9 Å, 1.9 Å, and 2.1 Å resolution,
respectively (Fig. 2a and Table 1). Although all three versions
contained various lengths of the N-terminus and also showed no
signs of degradation, we could observe interpretable electron
density only starting from residue V72 in all collected and refined
datasets. Therefore, we believe that the N-terminus adopts a
highly flexible conformation in the absence of substrate tRNAs.
The overall structure and domain arrangement and interface
between the rSAM and KAT domains of MinElp3 are almost
identical to DmcElp3 (Supplementary Fig. 2b,c). The main
difference relates to the Fe–S cluster loop region (aa 87–123) and
the Fe–S cluster itself, which were both completely unstructured
in all monomeric MinElp3s (Fig. 2a and Supplementary Fig. 2d).
We previously identified a Zn-binding motif in the central linker
region between the two domains that is coordinated by three
cysteine residues, which are strictly conserved in bacterial and
archaeal but missing in eukaryotic Elp3s (Fig. 2b)21. In our
MinElp3 structures, we could not locate any bound Zn-ions and
instead observed the formation of a disulfide bond between C384
and C389. Nevertheless, the equivalent sequence still obtains an
almost identical conformation, indicating that zinc might simply
contribute structural integrity in anaerobic bacteria. In addition,
we observed that the acetyl-CoA blocking loop (aa 466–486) is
positioned outside of the acetyl-CoA binding pocket, interacting
with the last visible residues of the N-terminus and also
contacting a neighboring symmetry mate (Fig. 2c and Supple-
mentary Fig. 2e). Using our DmcElp3-DCA structure as a
reference model, we are able to show that acetyl-CoA would also
fit seamlessly into the active site of MinElp3, indicating an almost
identical ligand coordination and active site organization. In
summary, bacterial and archaeal Elp3 proteins do not only share
high sequence conservation (Supplementary Fig. 2d and Supple-
mentary Fig. 3a), but also adopt an almost identical overall
domain arrangement indicating that they represent examples of
the genuine structure of all Elp3 proteins.
Functional comparison between bacterial and archaeal Elp3. It
was recently shown that the acetyl-CoA hydrolysis activity of
MinElp3 can be induced by the presence of in vitro transcribed
and truncated tRNAs and that this trigger does not require
the presence of an Fe–S cluster20. We compared the acetyl-CoA
hydrolysis rates of DmcElp3 and MinElp3 using purified endo-
genous bulk tRNAs from an Elp3-depleted yeast strain,
which carries naturally occurring modifications. Both proteins
exhibited low intrinsic basal hydrolysis rates in the absence
Table 1 Data collection, phasing and refinement statistics
DmcElp3
390–406GSGSG/E386A
DCA
PDB ID 6IA6
MinElp3
Δ1–19
PDB ID 6IA8
MinElp3
Δ1–46
PDB ID 6IAZ
MinElp3
Δ1–54
PDB ID 6IAD
Data collection
Space group C2221 P41212 P41212 P41212
Cell dimensions
a, b, c (Å) 73.56, 160.74, 93.00 63.44, 63.44, 250.22 63.35, 63.35, 250.06 62.97, 62.97, 248.25
α, β, γ (°) 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90
Wavelength 0.9184 1.0332 0.9184 0.9184
Resolution (Å)† 50–2.7(2.77–2.7) 50.0–1.9 (1.95–1.9) 50–1.9 (1.95–1.9) 50–2.05 (2.10–2.05)
Rmeas (%) 14.1 (209.9) 6.8 (158.2) 6.8 (99.7) 10.5 (162.9)
I/σ(I) 9.75 (0.81) 33.38 (1.73) 19.34 (1.82) 16.08 (1.76)
CC1/2 0.99 (0.29) 1.00 (0.59) 0.99 (0.62) 0.99 (0.62)
Completeness (%) 99.0 (98.1) 98.3 (83.4) 99.8 (98.0) 99.8 (98.1)
Redundancy 4.4 (4.0) 24.1 (16.42) 10.4 (8.3) 12.7 (12.8)
Refinement
Resolution (Å) 43.3–2.7 44.9–1.9 34.8–1.9 29.4–2.05
No. of reflections 15,372 41,022 41,281 32,466
Rwork/Rfree 22.3/26.9 18.4/20.7 19.5/21.7 19.7/22.3
No. of atoms
Protein 3017 3487 3476 3494
Ligand/ion 56 35 30 20
Water 0 124 163 109
B factors
Protein 83.7 50.4 47.1 51.1
Ligand/ion 125.4 87.6 88.5 93.1
Water 0 48.3 47.4 49.6
r.m.s deviations
Bond lengths (Å) 0.002 0.009 0.005 0.002
Bond angles (°) 0.552 0.847 0.730 0.635
Values in parentheses are for highest-resolution shell
†Resolution limits according to I/σ of 2 are 2.95 Å for DmcElp3390–406(GSGSG)/E386ADCA, 1.9 Å for MinElp3Δ1–19, 1.9 Å for MinElp3Δ1–46, 2.1 Å for MinElp3Δ1–54
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of tRNA, but MinElp3 as well as its mutated form lacking
the acetyl-CoA blocking loop (MinElp3466–486(GSGSG)) showed
robust
acetyl-CoA hydrolysis activity after addition of bulk tRNA. Fur-
thermore, we confirmed that MinElp3 binds to acetyl-CoA (Kd
135.4 ± 55.3 μM) and that deleting the acetyl-CoA blocking loop
does not have significant effects on its affinity to acetyl-CoA
in the absence of tRNA (Kd 107.7 ± 55.8 μM; Supplementary
Fig. 3b). DmcElp3, on the other hand, showed ~5-times reduced-
induced hydrolysis activity, which remained similarly weak
after deletion of the acetyl-CoA blocking loop region
(DmcElp3390–406(GSGSG); Fig. 2d). The varying levels of induci-
bility correlate well with differences in the binding affinities of
MinElp3 (Kd 50 ± 10 nM) and DmcElp3 (Kd ~1410 ± 230 nM)
towards Cy5-labeled in vitro transcribed tRNA(Dmc)tRNA-
Glu
UUC(CCA) (Supplementary Fig. 3c, d). As described above, the
flexible N-terminus shows the biggest sequence variation among
all known Elp3 proteins and also represents the main difference
between MinElp3 and DmcElp3 sequences (Fig. 3a). Therefore,
we analyzed if the extended flexible N-terminus of MinElp3 could
account for the differences in tRNA binding affinity using electro-
mobility shift assay (EMSA) and microscale thermophoresis
(MST). We observed strong interaction of the purified MinElp3
N-terminus (MinElp31-77) towards (Dmc)tRNAGluUUC and con-
firmed decreased affinities for N-terminally truncated MinElp3
proteins (Fig. 3b). We have designed and purified truncated
versions sampling the whole N-terminus based on secondary
structure predictions with the aim of conserving potential helices
and referring stability (Fig. 3a). The first 45 residues seem to have
a particularly strong contribution to the binding and deletion of
the complete N-terminus resulted in affinities comparable to
DmcElp3 (Fig. 3c). The decrease in tRNA affinities correlates well
with a strong decrease in tRNA-induced acetyl-CoA hydrolysis
activity of MinElp3, thereby confirming the specificity of the
induction and emphasizing the contribution of Elp3 N-termini to
tRNA binding and modification activity (Fig. 3d). As the
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Fig. 2 The crystal structure of MinElp3Δ1–54. a Overall structure of MinElp3Δ1–54 in cartoon representation. The rSAM domain (blue), KAT domain (orange),
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data are provided as a Source Data file
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N-terminal regions of Elp3 proteins are evolutionary very weakly
conserved, we were curious if exchanging these sequences
between species would affect the functionality. Strikingly, repla-
cing the N-terminus of MinElp3 (aa 1–69) with the respective
yeast (aa 1–95) or human (aa 1–78) sequences restored the tRNA
binding affinity of N-terminally truncated MinElp3 (Supple-
mentary Fig. 3d). As the tRNA-induced acetyl-CoA hydrolysis
rates remained unchanged in these chimeric proteins (Supple-
mentary Fig. 3e), it seems that although tRNA recognition is
conserved, species-specific mechanisms is required to trigger the
KAT activity.
The acetyl-CoA hydrolysis of Elp3 is tRNA dependent. Next, we
tested whether other nucleic acids or the absence of charged
amino acids could play a role for Elp3 activation. Both, bulk
tRNA from wild yeast strains carrying endogenous levels of
Elongator modifications, as well as de-acylated bulk tRNAs,
efficiently activated acetyl-CoA hydrolysis of MinElp3 (Fig. 4a
and Supplementary Fig. 4a, b). In contrast, neither polyU RNA
nor single stranded DNA showed any detectable induction of
hydrolysis rates. It has been an ongoing debate for many years,
whether Elp3 could also catalyze the canonical acetylation of
lysine residues in peptides and proteins. Therefore, we synthe-
sized and tested lysine-containing histone (H310–18 and H44–12)
and tubulin (Tubulin36–44) peptides, which have previously been
suggested18,51 as potential Elongator substrates and shown to be
suitable GCN5 substrates52–54 (Fig. 4b). Strikingly, neither his-
tone nor tubulin peptides are able to bind archaeal MinElp3
(Supplementary Fig. 4c) nor trigger its acetyl-CoA hydrolysis
reaction (Fig. 4a). Although in our hands all tested eukaryotic
Elp3 proteins are highly unstable and insoluble in the absence of
Elp1 and Elp2, we managed to obtain pure and homogenous KAT
domain from Chaetomium thermophilum (CtElp3435–574), a
thermophilic yeast strain55. All employed peptides failed to
induce the enzymatic activity of this isolated KAT domain from
this eukaryotic Elp3, even though the predicted peptide-binding
site is principally exposed due to the absence of the rSAM domain
(Supplementary Fig. 4d, e). Elp3 requires both domains to bind
tRNAs to activate acetyl-CoA hydrolysis, explaining the obser-
vation that bulk tRNA also failed to induce the enzymatic activity
of this eukaryotic Elp3 KAT domain.
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Fig. 3 N-terminus features of MinElp3 in tRNA binding and acetyl-CoA hydrolysis. a Sequence alignment of N-termini in selected Elp3 proteins. D. mccartyi
(DmcElp3) (YP307690), M. infernus (MinElp3) (YP003616086), M. jannaschii (MjElp3) (AAB99138), S. cerevisiae (ScElp3) (NP015239), D. melanogaster
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conserved residues are labeled in gradient green depending on the conservation scores. Basic residues are labeled in red. The predicted secondary
structure elements of MinElp3 are indicated on top of the aligned sequences. The individual start sites of the truncated N-terminal constructs are indicated.
b EMSA analyses of MinElp3s binding to yeast tRNASerUGA (Cy5-labeled). The samples were resolved in a 6% native PAGE and visualized using a Typhoon
scanner. Protein concentrations are given and positions of free tRNA and protein-tRNA complex are labeled. c MST analyses of MinElp3s binding to (Dmc)
tRNAGluUUC and the Kds are indicated, n= 3. d Acetyl-CoA hydrolysis reaction of different MinElp3 N-terminus truncations in the presence of endogenous
yeast bulk tRNA (Δelp3; UMY2916), n= 3. Data represent mean ± SEM. Source data are provided as a Source Data file
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The tRNA substrate selectivity of Elp3. We subsequently ana-
lyzed whether any tRNA might trigger the acetyl-CoA hydrolysis
of Elp3 or if the protein is able to select for suitable tRNA sub-
strates. We initially noticed no binding preference for different
in vitro transcribed tRNAs as the affinities for tRNACysGCA,
tRNASerUGA, and tRNAGluUUC are in a comparable low nano-
molar affinity range (Fig. 4c and Supplementary Fig. 5a).
Therefore, MinElp3 binds equally well to unmodifiable (tRNA-
Cys
GCA) and modifiable (tRNASerUGA/tRNAGluUUC) tRNAs and is
not capable of specifically recognizing the respective RNA base
present at position 34. We subsequently tested several in vitro
transcribed tRNAs, including tRNALysUUU, tRNASerUGA, tRNA-
Gly
UCC, and tRNACysGCA, for their potential to induce acetyl-CoA
hydrolysis. Whereas, tRNASerUGA and tRNAGlyUCC triggered the
hydrolysis as well as endogenous bulk tRNA, we did not observe
induction using tRNACysGCA, which harbors G34 (Fig. 4c). It
appears that Elp3 shows broad specificity for tRNA binding, but
strictly discriminates for modifiable U34-tRNAs at the step of
acetyl-CoA hydrolysis. In addition, Elp3 seems to work inde-
pendently from priming modification pathways, as endogenous
fully decorated and in vitro transcribed “naked” tRNAs show an
identical potential to induce its activity.
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Next, we analyzed whether Elp3 discriminates between
different modifiable tRNAs as cm5U34 primes for three down-
stream cascades, namely mcm5U34-, ncm5U34- and mcm5s2U34.
Therefore, we tested tRNAGluUUC, tRNAGlnUUG and tRNALysUUU
all harboring mcm5s2U34 and an invariant U35 on their ability to
induce acetyl-CoA activity. Strikingly, we observed regular levels
of activity for tRNALysUUU, but only intermediate activities for
tRNAGluUUC, tRNAGlnUUG and (Dmc)tRNAGluUUC (Fig. 4c).
Initially, we were curious, if U35 next to U34 could cause a
decreased acetyl-CoA hydrolysis activity, which is somehow
restored in for tRNALysUUU. As the substitution of U35 to either
purine (G35) or pyrimidine (C35) in yeast tRNAGlu did not elevate
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its ability to induce the activity of MinElp3 (Supplementary
Fig. 5b), we conclude that other determinants in tRNAGluUUC and
tRNAGlnUUG must be causative for their decreased activity.
We previously have shown that DmcElp3 not only uses its
central basic cleft to bind the ASL of a tRNA, but also employs
other basic residues residing in the N-terminus to make
additional contacts around the D-loop of tRNAs21. To investigate
whether these additional contacts are required for the enzymatic
activation in MinElp3, we tested whether the ASL (derived from
tRNASerUGA) is sufficient to activate Elp3. We observed that the
ASL by itself is not only sufficient to bind to full length MinElp3,
but also induces enzymatic activity at a comparable level as full
length tRNASerUGA (Fig. 4c, d). These observations are in line
with a report that MinElp3 can modify tRNAArg that misses D-
and T-loop20. We have previously reported that the ASL of
(Dmc)tRNAGluUUC is not sufficient to bind to bacterial DmcElp3.
In agreement with this data and the described importance of the
extended N-terminus in MinElp3, we observed that the central
basic cleft of MinElp3 (Supplementary Fig. 5c) is not sufficient for
efficient ASL binding. The affinity between the truncated
MinElp3Δ1–46 protein and the ASL alone are comparable to the
one of an unspecific polyU sequence towards full length MinElp3
(Fig. 4d). As the presence of a 3’CCA sequence, added during the
maturation of tRNAs, increases the affinity of full length MinElp3
for different tRNAs (Supplementary Fig. 5a), we speculate that
the extended N-terminus might be involved in both, the
recognition of the ASL and the 3’CCA regions.
Identification of active site residues in the KAT domain. To
identify the functional role of individual amino acids in the
acetyl-CoA binding pocket of Elp3, we introduced several
structure-guided mutations in MinElp3 (K150A, K266A, Q461A,
H463A, and Y517A) and tested them for acetyl-CoA hydrolysis
activity (Fig. 4e). Among these variants, only H463A still showed
acetyl-CoA hydrolysis activity, whereas all remaining MinElp3
mutations (K150A, K266A, Q461A, and Y517A) showed strongly
reduced or completely diminished tRNA-induced acetyl-CoA
hydrolysis activity. The reduced hydrolysis activity of the affected
mutants is not caused by alteration in their tRNA binding
(Supplementary Fig. 6a), but reduced acetyl-CoA binding for
K266A, Q461A, and Y517A. As K150A shows normal tRNA and
acetyl-CoA binding, we believe that it might be directly involved
the hydrolysis reaction (Supplementary Fig. 6b). Our previous
in vivo analyses of the equivalent positions in yeast Elp3 (ScElp3)
based on the apo structure of DmcElp3 confirmed the functional
relevance of these residues for the eukaryotic Elongator com-
plex21. To provide a complete mechanistic picture of the active
site, we have undertaken major efforts to co-crystalize different
Elp3 proteins in complex with various tRNA sequences, but to
date have not succeeded in obtaining analyzable crystals. Future
structural studies will take advantage of the identified mutants
and use different combinations of ASLs and acetyl-CoA deriva-
tives to lock Elp3 in different reaction intermediates.
Discussion
Catalytic reactions and regulatory mechanisms of tRNA mod-
ification enzymes are diverse and complex7. The enzymatically
active Elp3 subunit of Elongator contains two functional
domains, utilizes multiple cofactors, and conducts a unique uri-
dine base modification specifically found only at the wobble base
position of tRNAs. Although, all known Elp3s share high
sequence similarity, eukaryotic Elp3s are embedded in the large
Elongator complex and the modification reaction requires five
other Elongator subunits and several regulatory factors56,57.
Nevertheless, it was recently shown that (m)cm5U34 is present in
tRNAs from H. volcanii indicating that archaeal Elp3s must be
able to conduct a very similar modification reaction as the fully
assembled eukaryotic Elongator complex58. In this study, we
provide a comprehensive structural and functional comparison of
bacterial, archaeal and eukaryotic Elp3 proteins and their KAT
domains.
Our results clearly illustrate that Elp3 can recognize and
respond to in vitro transcribed tRNA substrates as well as to
endogenous bulk tRNAs from yeast. We also demonstrate that a
synthesized ASL can induce enzyme activity, whereas other tRNA
sequences (e.g. tRNAGluUUC, tRNAGlnUUG, (Dmc)tRNAGluUUC,
and tRNACysGCA) show reduced or no activity at all. These data
indicate that specific bases in the ASL of tRNA are necessary to
activate Elp3 and that for certain modifiable tRNAs additional
modification might also be necessary for full activation (Supple-
mentary Fig. 7). Thus, we searched the MODOMICS database1 of
experimentally proven tRNA modifications in eukaryotic organ-
isms and found that there are two specific modifications in the
ASL of tRNAGluUUC and tRNAGlnUUG, which are not found in
tRNALysUUU or other modifiable tRNAs (Fig. 5a). They carry a
pyrimidine modification at position 32 (either Cm32 or pseudo-
uridine (Ψ32)), which is absent in the used in vitro transcribed
tRNAs. The lack of Cm32 is known to affect the anticodon stem
loop structure and function7,59, and thereby could explain the
reduced activity of Elp3 observed with these two tRNA species.
Several studies have reported on the cross-talk and inter-
dependency of tRNA modification networks60 and the link
between these modifications and Elp3 activation needs to be
investigated in the future.
By combining all available biochemical and structural data, we
can conclude a potential mechanism of regulation and a
sequential order of the Elp3 reaction cycle (Fig. 5b). (i) Modifiable
and non-modifiable tRNAs bind to Elp3 with similar affinity; (ii)
the N-terminus of Elp3 checks for the presence of 3’CCA and
guides the ASL into a correct position within the central cleft of
Elp3; (iii) tRNA binding displaces the acetyl-CoA blocking loop
and could stimulate local structural rearrangement to facilitate
acetyl-CoA binding, (iv) acetyl-CoA binding is secured and
hydrolysis is initiated only by the correct modifiable substrate
tRNAs in analogy to canonical acetyl transferases; (v) the released
acetyl group is transported to the SAM domain; (vi) the Fe–S
cluster generates a 5’dA-radical; (vii) an acetyl radical is generated
via the contact of the acetyl group with the 5’dA-radical (viii) the
acetyl radical is transferred onto U34 bound in close proximity
and the modified tRNA leaves the complex.
Foremost, the presented crystal structures of DmcElp3-DCA
and MinElp3 show striking similarities, indicating a common fold
and domain architecture of all Elp3 family members. We con-
firmed the importance of several previously described active site
residues for ligand binding and acetyl-CoA hydrolysis activity.
Whereas, K266, Q461, and Y517 stabilize the binding of acetyl-
CoA during the hydrolysis reaction, K150 might mimic a sub-
strate lysine residue and trigger the acetyl transfer in the direction
of the rSAM domain and the bound tRNA substrate. Our high
resolution structural information of the unbound and ligand-
bound active site of the Elp3 KAT domain might facilitate the
design and optimization of highly specific small compound
inhibitors as research tools or for therapeutic applications.
In this respect, we established an acetyl-CoA hydrolysis assay,
which allows us to quantitatively investigate the enzymatic
activity of Elp3 as well as its substrate selectivity. Importantly, the
assay format uncouples the KAT-based activity from the reduc-
tive SAM cleavage by the Fe–S cluster in the rSAM domain,
which would require fully anaerobic reconstitution of the
involved Fe–S cluster. We have employed this divide and conquer
approach to identify the mechanism of substrate selection and
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specificity of Elp3 and Elongator. Although, we have repeatedly
failed to reproduce a previously described modification assay that
was based on isotope labelling20, we are able to show that archaeal
Elp3 is able to discriminate between modifiable and unmodifiable
tRNA substrates at the step of initiating acetyl-CoA hydrolysis.
Notably, the KAT domain of Elp3 responds specifically to
tRNA molecules, whereas the addition of previously suspected
peptide substrates or other types of nucleic acids does not trigger
any detectable enzymatic activity. In particular, no stimulation of
acetyl-CoA hydrolysis activity was observed in the case of an
isolated eukaryotic Elp3 KAT domain. Although additional
peptide binding sites on other eukaryotic Elongator subunits
cannot be excluded, it appears, that the exposure of the hypo-
thetical peptide binding site, which is normally blocked by the
rSAM domain, does not stimulate a peptide-induced acetyl
transfer reaction.
The recognition of substrate tRNAs by Elp3 is independent of
other tRNA modifications, but for a subset of tRNA species
priming ASL modification might increase the necessary ASL
conformation and modification activity. The N-termini of Elp3
proteins seem to contribute to the specific recruitment of mature
tRNAs carrying a 3’CCA, promote proper binding of the ASL into
the active site and facilitate sequence-specific tRNA selection and
specificity by sequence variation in different species. In summary,
our data suggest that tRNAs represent the exclusive substrate for
the eukaryotic Elongator complex as well as bacterial and archaeal
Elp3 proteins, which all represent genuine tRNA editing enzymes.
Methods
Protein expression and purification. The MinElp3, CtElp3, ScElp3, and HsElp3
ORFs were synthesized and cloned into pETM30. The respective sequences are
listed in Supplementary Table 1. Mutations were introduced using mutagenesis and
truncations or N-termini of MinElp3 were made using PCR followed by restriction
digestion and insertion of the amplified gene fragments into pETM30 or pETM11.
The detailed sequences of the respective primers are listed in Supplementary
Table 2. The correct sequences of all constructs were confirmed by sequencing. All
plasmids, including the DmcElp3 constructs21, were transformed into the strain
BL21 (DE3) CodonPlus-RIL competent cells. Transformed cells were grown in TB
broth and protein expressions were induced by isopropyl β-D-1-
thiogalactopyranoside IPTG (1 mM) for overnight at 18 °C. The cells were collected
and lysed in lysis buffer (50 mM HEPES, pH 7.5, 300 mM NaCl, 2 mM DTT, 10%
glycerol, 1 mM MgCl2, protease inhibitor, lysozyme and DNase). The spun
supernatant was obtained by centrifugation at 80,000 × g at 4 °C and subjected to a
GSTPrep column for protein binding. The target protein was eluted by applying
elution buffer containing 50 mM HEPES, pH 7.5, 300 mM NaCl, 2 mM DTT, 10%
glycerol and 18 mM GSH. The protein elute was collected and mixed with GST-
TEV protease and dialyzed overnight to cleave off the GST tag. The protein
solution was then applied back to a GSTPrep column to remove the GST-TEV
protease and uncleaved protein. The flow-through was collected and applied to a
heparin column and the protein was eluted by applying the gradient elution
method (buffer condition: 20 mM HEPES, pH 7.5, 3 M KCl, 2 mM DTT). The
protein elute was applied to a size-exclusion chromatography column (S200, 26/60,
GE Healthcare) and the buffer was exchanged to 20 mM HEPES, pH 7.5, 150 mM
NaCl, 5 mM DTT. The protein concentration was measured and the concentrated
purified protein was aliquoted and stored at −80 °C or subjected to crystallization
trials. Protein mass of samples was determined using MALS/RALS (Malvern)
equipped with a S200 gel filtration column (15/30, GE Healthcare). In the case of
His-tagged MinElp31–77 protein, the purification step and conditions were the same
as described above but using NiNTA beads for protein binding followed by 250
mM imidazole elution.
Protein crystallization and structure determination. Purified DmcElp3390–406
(GSGSG)/E386A was concentrated to 10 g/L and mixed with 1 mM DCA (Jena
Bioscience). The protein solution was combined with equal amount of crystal-
lization buffer (100 mM MES, pH 6.3 and 4% PEG 4000). The purified MinElp3
protein solutions (12 mg/ml) was prepared and crystallized at 22 °C in the con-
dition of 0.1 M phosphate/citrate (pH 3.8), 0.2 M LiSO4 and 12% PEG1000 or 0.1
M citrate (pH 3.8), 0.1 M LiCl and 17% PEG6000. All crystals were grown suing
hanging-drop vapor-diffusion method. Crystals appeared after 3 days and were
cryo-protected at the seventh day in a 30% glycerol solution and flash frozen in
liquid nitrogen. Datasets were collected on a Pilatus 6M-F detector at the BESSY II
synchrotron (Berlin) for DmcElp3-DCA, MinElp3Δ1–46, and MinElp3Δ1–54, and
DESY synchrotron (Hamburg) for MinElp3Δ1–19. Data processing were performed
with XDS/XSCALE61 and the structures were solved using Phaser62 and molecular
replacement approach based on the existing DmcElp3 model (5L7L) and further
refined using Phenix63. The refinement statistics of the respective models are given
in Table 1. The geometry and stereochemistry of the models were validated using
MolProbity64. Structural models and superimpositions were analyzed and gener-
ated using Pymol65 and Coot66. For additional model validation of the presence of
DCA, simulated annealing omit maps were calculated using phenix63,67. The
electrostatic potential was calculated using APBS66 and PDB2PQR.
Peptide synthesis and purification. We synthesized three peptides (H3:
YSTGGKAPRK; H4: YRKGGKGLGK; TK40: YMPSDKTIGG) that are known as
acetyltransferase substrates18,50. We also include an additional tyrosine residue for
facilitated concentration determination. All peptides were synthesized as C-
terminal amides on a CEM Liberty Blue Microwave Peptide Synthesizer at 0.1
mmol scale by using standard Fmoc-solid phase peptide synthesis methodology on
Rink Amide AM Resin (0.9 mmol/g, 100–200 mesh)68. As recommended by
manufacturer DIC/Oxyma Pure in DMF were used as coupling activators (in
fivefold molar excess of Fmoc-AA-OH) and 10% piperazine in NMP/ethanol (9:1)
for deprotection. Following the final deprotection, N-terminal acetylation was
performed with 10% acetic anhydride in DMF. Cleavage was performed for 3 h at
room temperature with TFA/H2O/TIS (94/3/3). Following cleavage TFA solution
was concentrated under nitrogen stream for 30 min. The concentrated peptide
solution was triturated with cold diethyl ether and the precipitate was centrifuged.
Precipitated peptide was washed with diethyl ether and ethyl acetate (twice) and
dried under vacuum overnight. Crude peptide was dissolved in 6M urea and
purified by semipreparative RP-HPLC on C18 column. The purified fractions were
collected, frozen, and lyophilized. Purified peptides were analyzed on analytical RP-
HPLC and confirmed by electrospray ionization mass spectrometry (ESI-MS).
Peptides labeling with fluorescence probe was carried out after the solid phase
peptide synthesis on the resin. In brief, dye conjugation was performed after
coupling and deprotection of the last amino acid on the fully protected (except the
N-terminal amino group) peptide while still attached to the resin. Peptide resin (15
µmols) slurry was prepared in 100 µl anhydrous DMF (VWR Chemicals). Cya-
nine5 NHS ester (Abcam) was dissolved in anhydrous DMSO (Sigma) and it was
added to peptide-resin slurry at equal molar ratio and the incubation was carried
out at room temperature for 2 h. i-Pr2NEt - N, N-Diisopropylethylamine (DIPEA,
50 mM) was then added dropwise to the slurry solution to adjust pH to 8.5 and
followed by stirring overnight. The Cy5-peptide-resin was extensively washed with
several solutions as follows: DMF, DCM, isopropanol, ethyl acetate, and dried
under vacuum. Cleavage protocol and all post synthetic steps were the same as
previously described procedure for non-labeled peptides. Cy5-labeled peptides
were further purified using HPLC chromatography on the RP C18 column. Pur-
ified Cy5-peptides were lyophilized and stored at −80 °C.
Yeast culture and bulk tRNA purification. The two S. cerevisiae strains
(UMY2893 and UMY2916)69 were cultured from a single colony at 30 °C for
overnight with agitating at 200 rpm. The cells (1L, OD600 at 0.2) were then further
cultured until OD600 at 1.5 and followed by centrifugation at 3000 × g at 4 °C for
10 min to collect cells. The cells were then washed with H2O and resuspended in
30 ml TE buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA) with addition of 0.1 M
NaOAc and 1% SDS. A cryo-mill operated with liquid nitrogen was used to grind
and lyse cells. The powder was thawed on ice and followed by adding 30 ml TRIzol
(Thermo Fisher Scientific). The solution was vortexed for 1 min and incubated at
RT for 20 min. The RNA was purified by chloroform extraction and followed by
two step precipitations in 8M LiCl and followed by 0.3 M NaOAc and 75% EtOH
precipitation at −20 °C for overnight. The RNA was spun into a pellet by cen-
trifugation at 4000 × g at 4 °C for 30 min. The pellet was washed in 75% EtOH for
three times, air-dried and resuspended in 3 ml 10 mM NaOAc pH 5.2. The RNA
was then further applied to a S200 gel filtration column (HiLoad 26/600) equili-
brated in 10 mM NaOAc (pH 5.2) to purify tRNAs. The tRNA fractions were
pooled and tRNA was precipitated using the method described above and resus-
pended in 10 mM NaOAc (pH 5.2) for storage.
Acetyl-CoA hydrolysis. Proteins (10 μM) were mixed with 100 μM acetyl-CoA
and tRNAs (2 μM) or peptides (2 μM) and incubated at 37 °C for 20 min. The
reaction was applied to a 3 kDa cutoff concentrator (EMD Millipore) to remove
proteins. The flow through (50 μL) was collected and transferred to a 96-well plate.
Acetyl-CoA quantity was determined using an acetyl-CoA assay kit (Sigma) in
accordance to manufacturer’s instructions. An end-point assay was performed and
the fluorescence intensity (λExcitation 535 nm; λEmission 587 nm) was measured using
a plate reader (TECAN); n= 3.
tRNA constructs and in vitro transcription and purification. All tRNA genes
were amplified by PCR using genomic DNA from yeast as template and the pri-
mers that contain the complementary sequences to pUC19. Restriction free cloning
method was performed to construct all amplified tRNA genes downstream of a T7
promoter. Downstream of every gene a BpiI cutting site was introduced, which is
used to linearize the DNA for run off T7 RNA polymerase-driven in vitro tran-
scription. The addition of CCA to the 3′-end of tRNA genes was performed by
simple mutagenesis of the template construct. For in vitro transcription (250 μL
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reaction), the reaction contained linear DNA template (20 ng), 8 mM of each NTPs
(ATP, GTP, and UTP), 6 mM of CTP and 2mM of Cy5-lableled CTP, T7 RNA
polymerase (0.5 g/L), RNasin (0.025 g/L), MgCl2 (2~8 mM), pyrophosphatase (1 U)
and the reaction buffer (40 mM Tris, pH 8.0, 5 mM DTT, 1 mM spermidine, and
0.01% Triton X-100). All the ingredients were mixed at RT first followed by the
incubation at 37 °C for overnight. The next day, the RNase free DNase (2U) was
added to the reaction for further incubation at 37 °C for 15 min. The reaction was
then stopped by the addition of EDTA (50 mM). The transcribed tRNA was
purified using a DEAE column directly70 and eluted tRNA fractions were pooled
and precipitated in EtOH at −80 °C for overnight. The tRNA containing solution
was subjected to centrifuge at 20,000 × g at 4 °C for 30 min. The pellet was then
washed in 70% EtOH, air-dried and re-dissolved in annealing buffer (20 mM
HEPES, pH 7.5, 50 mM NaCl, and 50 mM KCl). Cy5-labeled tRNA was first
renatured by heating in the annealing buffer at 80 °C for 2 min and slowly cooled to
60 °C using a thermo-cycler. MgCl2 was added to tRNA and the procedure con-
tinued by cooling down to 25 °C. Annealed tRNAs were further purified by
applying them to a gel filtration column (S75, 10/30) equilibrated in 20 mM
HEPES, pH 7.5, 150 mM NaCl, 5 mM DTT, and 1 mM MgCl2. The purified tRNAs
were then stored at −80 °C.
EMSA. Cy5-labeled RNA oligos (ASL yeast tRNASerUGA 5′-GACAGACUU-
GAAAUCUGUU-3′ and polyU 5′-UUUUUUUUU-3′) were purchased from
Sigma. Proteins were serially diluted, and Cy5-labeled RNA (~1 ng/lane) as well as
Cy5-labeled tRNA were added for incubation at 25 °C for 30 min. The RNA-
protein complex and free RNA were resolved by 6% native gel and separated by
running for 6 h at 100 V at 4 °C. The gels were scanned using Typhoon (GE
Healthcare) and the images were analyzed and viewed by ImageQuant (GE
Healthcare).
Microscale thermophoresis. MinElp3 (15 g/l) or DmcElp3 (10 g/l) were prepared
in twofold serial dilutions in PCR tubes. The Cy5-labeled tRNA (30 nM) or Cy-
labeled H3 peptide (10 nM) was mixed with diluted proteins with equal amount for
incubation at 25 °C for 15 min. The samples were subjected to premium capillary
tubes and analyzed using MO. CONTROL (Nanotemper) with the temperature
setting at 25 °C. The Kds were calculated based on triplicate measurement using
MO. Affinity software (Nanotemper), n= 3.
Isothermal titration calorimetry measurements. ITC was performed with Nano
ITC 2G (TA Instruments). To measure the MinElp3 interaction with acetyl-CoA,
histone 3 peptide or tubulin peptide, proteins were dialyzed against the ITC buffer
(20 mM HEPES, pH 7.5, 150 mM NaCl, and 1 mM β-mercaptoethanol) extensively
overnight at 4 °C. The reaction cell was filled with proteins (10–12 µM); whereas,
the ligands were prepared in the same ITC buffer at 2.47 mM (except H3 was 1.6
mM) and loaded into a dosing syringe. Each injection (10 µl) was performed in 300
s intervals. All experiments were conducted at 25 °C with a stirring rate of 250 rpm.
The results were analyzed using NanoAnalyze software (TA instruments).
Data availability
Data generated in this publication are available from corresponding author on reasonable
request. The atomic coordinates and respective structure factors for DmcElp3-DCA
(PDB ID 6IA6), MinElp3Δ1-19 (PDB ID 6IA8), MinElp3Δ1-46 (PDB ID 6IAZ) and
MinElp3Δ1-54 (PDB ID 6IAD) have been validated and deposited at the European
Protein Data Bank. The source data underlying Figs 3, 4, Supplementary Fig. 1, 2, 3, 4, 5
and the numerical values of the graphs, including Figs 2, 3, 4 and Supplementary Fig. 3,
4, 5 and 6 are provided as a Source Data file.
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